55 related articles for article (PubMed ID: 27629742)
1. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
[TBL] [Abstract][Full Text] [Related]
2. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
3. Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Li YL; Li YF; Li HF; Lv HQ; Sun DZ
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28559386
[TBL] [Abstract][Full Text] [Related]
4. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
[TBL] [Abstract][Full Text] [Related]
5. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts.
Mills KA; Quinn JM; Roach ST; Palisoul M; Nguyen M; Noia H; Guo L; Fazal J; Mutch DG; Wickline SA; Pan H; Fuh KC
Sci Rep; 2019 Mar; 9(1):4762. PubMed ID: 30886159
[TBL] [Abstract][Full Text] [Related]
6. PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker.
Ou X; Zhang Y; Xu Y; Liu Y; Tu W; Hu C; Liu Y
Cell Death Dis; 2024 Apr; 15(4):294. PubMed ID: 38664379
[TBL] [Abstract][Full Text] [Related]
7. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor.
Peng S; Fan S; Li X; Wang L; Liu H; Zhou M; Wang L; Shen S; Li G
Cancer Sci; 2007 Mar; 98(3):341-9. PubMed ID: 17270023
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
[TBL] [Abstract][Full Text] [Related]
9. AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking.
Maacha S; Hong J; von Lersner A; Zijlstra A; Belkhiri A
Neoplasia; 2018 Oct; 20(10):1008-1022. PubMed ID: 30189359
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ret finger protein correlates with outcomes in endometrial cancer.
Tsukamoto H; Kato T; Enomoto A; Nakamura N; Shimono Y; Jijiwa M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
Cancer Sci; 2009 Oct; 100(10):1895-901. PubMed ID: 19650860
[TBL] [Abstract][Full Text] [Related]
11. p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
Chen J; Li S; Xiao Y; Zou X; Zhang X; Zhu M; Cai M; Xie D
BMC Cancer; 2017 Dec; 17(1):846. PubMed ID: 29237424
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract][Full Text] [Related]
13. NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression.
Hwang YC; Lu TY; Huang DY; Kuo YS; Kao CF; Yeh NH; Wu HC; Lin CT
Am J Pathol; 2009 Jul; 175(1):342-54. PubMed ID: 19541936
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Expression and Clinical Significance of WWP1 Protein in Nasopharyngeal Cancer.
Chen H; Li C; He S; Ling J; Zhao H; Zhuo X
J Histochem Cytochem; 2024 May; ():221554241255722. PubMed ID: 38804681
[TBL] [Abstract][Full Text] [Related]
15. Predicting the overall survival and progression-free survival of nasopharyngeal carcinoma patients based on hemoglobin, albumin, and globulin ratio and classical clinicopathological parameters.
Chen Z; Ling J; Zhang S; Feng Y; Xie Y; Liu X; Hou T
Head Neck; 2024 Apr; ():. PubMed ID: 38646952
[TBL] [Abstract][Full Text] [Related]
16. Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells
Li T; Tian Y; Wang Y; Cui Z; He Z; Wu X; Zhang Y; Jiang H
Front Oncol; 2021; 11():724251. PubMed ID: 35117986
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of
Huang Y; Jian W; Zhao J; Wang G
Onco Targets Ther; 2018; 11():2177-2184. PubMed ID: 29713186
[TBL] [Abstract][Full Text] [Related]
18. Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple Cohorts.
Guo YM; Chen JR; Feng YC; Chua MLK; Zeng Y; Hui EP; Chan AKC; Tang LQ; Wang L; Cui Q; Han HQ; Luo CL; Lin GW; Liang Y; Liu Y; He ZL; Liu YX; Wei PP; Liu CJ; Peng W; Han BW; Zuo XY; Ong EHW; Yeo ELL; Low KP; Tan GS; Lim TKH; Hwang JSG; Li B; Feng QS; Xia X; Xia YF; Ko J; Dai W; Lung ML; Chan ATC; Lo DYM; Zeng MS; Mai HQ; Liu J; Zeng YX; Bei JX
Adv Sci (Weinh); 2020 May; 7(10):1903727. PubMed ID: 32440486
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma.
Lu R; Wang Y; Xu X; Xie S; Wang Y; Zhong A; Zheng H; Yu Y; Gao X; Guo L
BMC Biochem; 2018 Jul; 19(1):6. PubMed ID: 30064372
[TBL] [Abstract][Full Text] [Related]
20. AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers.
Balaji K; Vijayaraghavan S; Diao L; Tong P; Fan Y; Carey JP; Bui TN; Warner S; Heymach JV; Hunt KK; Wang J; Byers LA; Keyomarsi K
Mol Cancer Res; 2017 Jan; 15(1):45-58. PubMed ID: 27671334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
